Commentary: The association between hormone-replacement therapy and non –small cell lung cancer in women

Titan and colleagues have performed secondary data analyses from data collected by the multicenter randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (1993-2001).1 This longitudinal screening trial collected detailed clinical data, including non –small cell lung cancer (NSCLC) incidence, postdiagnosis therapies, and detailed hormone use. The primary finding of their analyses is that hormone-replacement therapy (HRT) is associated with a 20% reduction in developing NSCLC. However, HRT was not associated with improved survival following dia gnosis and treatment.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research